[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![AmitxUpdates Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1155779125744812032.png) Amit [@AmitxUpdates](/creator/twitter/AmitxUpdates) on x XXX followers
Created: 2025-07-25 14:54:57 UTC

Dr Reddy's Q1FY26 was a revenue miss ($398M, -X% QoQ) on US pressure from gRevlimid, but strong ex-US growth keeps Street hopeful. Analysts expect earnings to improve FY26–27 on new launches, NRT growth & easing gRevlimid drag. #Pharma #DrReddys #Earnings

![](https://pbs.twimg.com/media/Gwtg57zbgAACo_Y.jpg)

XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1948758877702590930/c:line.svg)

**Related Topics**
[$398m](/topic/$398m)
[dr reddys](/topic/dr-reddys)

[Post Link](https://x.com/AmitxUpdates/status/1948758877702590930)